Machine signal
Active cluster buy — 3 distinct insiders, $0, window ends Sep 28, 2026.
Figures computed from official regulatory filings — .
Ownershipinsiders 3.96% · institutions 52.25%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ABIVAX only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
25 buys36 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Marc De Garidel | Sell | $306.2K | AMF |
| Marc De Garidel | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 56 | AMF |
| Didier Blondel | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 70ClusterFirst in 12mo | AMF |
| Corinna zur Bonsen-Thomas | ExerciseD (derivative) | $119.3K | AMF |
| Marc De Garidel | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 35 | AMF |
| Sylvie Grégoire | Sell | $467.6K | AMF |
| Sylvie Grégoire | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 55ClusterFirst in 12mo | AMF |
| Marc De Garidel | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 52Cluster | AMF |
| Marc De Garidel | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 62First in 12mo | AMF |
| marc de garidel thorontrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 43 | AMF |
| marc de garidel thorontrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 32 | AMF |
| Dominik Hochli | AwardD (derivative) | $58.9K | AMF |
| Camilla Soenderby | AwardD (derivative) | $183.9K | AMF |
| June Kim | AwardD (derivative) | $178K | AMF |
| marc de garidel thorontrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 34 | AMF |
| Sofinnova Partners SAStrack record | Sell | $116.3M | Unusual size | AMF |
| Sofinnova Partners SAStrack record | Sell | $6M | AMF |
| marc de garidel thorontrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 32 | AMF |
| Corinna zur Bonsen-Thomas | Sell | $821.9K | AMF |
| Corinna zur Bonsen-Thomas | Sell | $792.5K | AMF |
| Corinna zur Bonsen-Thomas | ExerciseD (derivative) | $220.6K | AMF |
| Corinna zur Bonsen-Thomas | ExerciseD (derivative) | $73.9K | AMF |
| marc de garidel thorontrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 35 | AMF |
| Sofinnova Partners SAStrack record | Sell | $57.3M | Unusual size | AMF |
| Sofinnova Partners SAStrack record | Sell | $55.6M | Unusual size | AMF |